Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I.
We studied whether or not an anti-beta 2-glycoprotein I antibody (aGPI) had lupus anticoagulant-like activity, employing the diluted Russel viper venom time (dRVVT) and kaolin clotting time (KCT) as indices. aGPI prolonged the dRVVT and KCT of beta 2-glycoprotein I (GPI)-depleted normal plasma in the presence of extrinsic GPI. This prolongation of the dRVVT and KCT occurred immediately after the addition of aGPI and GPI, and was subsequently enhanced further in a time-dependent manner. The GPI/aGPI combination was judged to have lupus anticoagulant-like activity by the dRVVT-platelet neutralization test, but this was not confirmed by a lupus anticoagulant-specific test, i.e., the activated partial prothrombin time (APTT) using hexagonal phospholipid. From these findings, it can be concluded that aGPI has lupus anticoagulant-like activity in the presence of GPI, but may be a partially or considerably different antiphospholipid antibody from lupus anticoagulant. Further investigations may be needed to clarify this point.
Matsuda
J
J
Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Gohchi
K
K
Tsukamoto
M
M
Saitoh
N
N
Asami
K
K
Hashimoto
M
M
D000906:Antibodies / Q000494:pharmacology*; D001053:Apolipoproteins / Q000276:immunology* / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects*; D006023:Glycoproteins / Q000276:immunology* / Q000494:pharmacology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000494:pharmacology; D010314:Partial Thromboplastin Time; D011517:Prothrombin Time; D013997:Time Factors; D053482:beta 2-Glycoprotein I
D000906:Antibodies; D001053:Apolipoproteins; D006023:Glycoproteins; D016682:Lupus Coagulation Inhibitor; D053482:beta 2-Glycoprotein I